Merck & Co Inc
These innovative biotech stocks have a good chance of breaking out in 2025
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and portfolio manager at Emerald Advisors, […]
Read More
Stocks making the biggest moves premarket: General Mills, Nvidia, Jabil and more
Check out the companies making headlines before the bell. General Mills — The maker of consumer food products such as Cheerios and Cocoa Puffs sank 5% after trimming its outlook for 2025. General Mills said it now expects adjusted earnings per share to fall between 3% and 1%. The company previously expected that figure to […]
Read More
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. The oral drug has not yet […]
Read More
Investor Bill Nygren just bought this pharma giant, names two AI-adjacent stocks he likes going into 2025
Investors should consider scooping up shares of this pharmaceutical giant trading at a discount, according to longtime value investor Bill Nygren. ” Merck is attractive on a standalone basis, and it’s got really good portfolio characteristics,” said the portfolio manager at Oakmark Funds, who bought shares in the third quarter. “We’re heavy in financials, we’re […]
Read More
How President-elect Donald Trump may impact investors in these 8 market sectors
FA Playbook How President-elect Donald Trump may impact investors in these 8 market sectors Published Tue, Nov 26 202412:24 PM EST Greg Iacurci@GregIacurci Lorie Konish WATCH LIVE Source
Read More
DOGE coming: Beware these stocks that get the most revenue from the government
Investors should be wary of the impacts several companies may bear from the cost-cutting goals of President-elect Donald Trump’s Department of Government Efficiency, or DOGE, according to TD Cowen. “The announcement of DOGE has led to concerns about future revenue and profitability of USG [United States government] contractors,” analyst Roman Schweizer said in a Friday […]
Read More
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But […]
Read More
S&P 500 futures slip after Microsoft reports; traders brace for key inflation data: Live updates
Traders react after the closing bell on the floor at the New York Stock Exchange on March 20, 2024. Brendan Mcdermid | Reuters Stock futures slid on Wednesday evening, as Wall Street absorbed a fresh batch of earnings reports from megacap technology names. S&P 500 futures lost 0.3%, and Nasdaq 100 futures fell 0.4%. Futures […]
Read More
Stocks making the biggest moves midday: Taiwan Semi, On Semi, Delta Air and more
Check out the companies making headlines in midday trading. Spotify — The music streaming platform advanced 2% after Wells Fargo named it a top stock pick . Analyst Steven Cahall cited Spotify’s rising profit margins, strong product mix and evolving record label relationships as catalysts while reiterating an outperform rating on the stock. Robinhood — […]
Read More
These dividend-paying stocks could be in the ‘early innings’ of a rally
It’s time to step back into health-care stocks, according to Wolfe Research. The sector was one of the worst performing over the past month, pulling back over 4% from September to October, technical analyst Rob Ginsberg wrote in a note on Tuesday. “As evidenced by XLV [Health Care Select Sector SPDR Fund], price is back […]
Read More